Case number 1:23-cv-00633
Teva Pharmaceuticals International GmbH et al v. BendaRx Corp. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 23, 2023 | 10 | MOTION to Dismiss for Failure to State a Claim - filed by BendaRx Corp.. (Attachments: # 1 Text of Proposed Order, # 2 7.1 Corporate Disclosure Statement)(Hunter, Travis) (Entered: 06/23/2023) (7.1 Corporate Disclosure Statement) (2) |
| Jun 23, 2023 | 10 | MOTION to Dismiss for Failure to State a Claim - filed by BendaRx Corp.. (Attachments: # 1 Text of Proposed Order, # 2 7.1 Corporate Disclosure Statement)(Hunter, Travis) (Entered: 06/23/2023) (Text of Proposed Order) (1) |
| Jun 23, 2023 | 11 | OPENING BRIEF in Support re 10 MOTION to Dismiss for Failure to State a Claim filed by BendaRx Corp..Answering Brief/Response due date per Local Rules is 7/7/2023. (Attachments: # 1 Certificate of Compliance)(Hunter, Travis) (Entered: 06/23/2023) (Certificate of Compliance) (1) |
| Jun 23, 2023 | 12 | NOTICE of Appearance by Nathalie Anne Freeman on behalf of BendaRx Corp. (Freeman, Nathalie) (Entered: 06/23/2023) (1) |
| Jun 23, 2023 | 11 | OPENING BRIEF in Support re 10 MOTION to Dismiss for Failure to State a Claim filed by BendaRx Corp..Answering Brief/Response due date per Local Rules is 7/7/2023. (Attachments: # 1 Certificate of Compliance)(Hunter, Travis) (Entered: 06/23/2023) (Main Document) (24) |
| Jun 23, 2023 | 10 | MOTION to Dismiss for Failure to State a Claim - filed by BendaRx Corp.. (Attachments: # 1 Text of Proposed Order, # 2 7.1 Corporate Disclosure Statement)(Hunter, Travis) (Entered: 06/23/2023) (Main Document) (2) |
| Jun 16, 2023 | 9 | WAIVER OF SERVICE returned executed by Teva Pharmaceuticals International GmbH, Cephalon, LLC: For BendaRx Corp. waiver sent on 6/12/2023, answer due 9/11/2023. (Hoeschen, Nathan) (Entered: 06/16/2023) (1) |
| Jun 15, 2023 | 8 | STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 06/15/2023) (2) |
| Jun 14, 2023 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) (Entered: 06/14/2023) (0) |
| Jun 9, 2023 | 7 | Summons Issued as to BendaRx Corp. on 6/9/2023. (apk) (Entered: 06/12/2023) (2) |
| Jun 9, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Janus Henderson Group PLC, Corporate Parent BlackRock Institutional Trust Company, N.A. for Eagle Pharmaceuticals, Inc. filed by Eagle Pharmaceuticals, Inc. (apk) (Entered: 06/12/2023) (1) |
| Jun 9, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd., Corporate Parent Cupric Holding Co. LLC for Cephalon, LLC; Corporate Parent Teva Pharmaceutical Industries Ltd., Corporate Parent Capital Research Global Investors for Teva Pharmaceuticals International GmbH filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (apk) (Entered: 06/12/2023) (3) |
| Jun 9, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) (SEE ATTACHED PATENT REPORTS) (Attachments: # 1 Patent/Trademark Report, # 2 Patent/Trademark Report)(apk) (Entered: 06/12/2023) (Main Document) (1) |
| Jun 9, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/5/2023. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 11/5/2025. (apk) (Entered: 06/12/2023) (2) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit A) (26) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit B) (30) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit C) (28) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit D) (30) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit E) (29) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit F) (30) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit G) (28) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit H) (30) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit I) (18) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit J) (30) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit K) (28) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit L) (22) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit M) (2) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit N) (2) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit O) (2) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit P) (2) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit Q) (3) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit R) (2) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit S) (5) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit T) (9) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit U) (14) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit V) (7) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Exhibit W) (4) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Civil Cover Sheet) (3) |
| Jun 9, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 06/12/2023) (3) |
| Jun 9, 2023 | 1 | COMPLAINT filed against BendaRx Corp. ( Filing fee $ 402, receipt number ADEDC-4155668.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC, Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Civil Cover Sheet)(apk) (Entered: 06/12/2023) (Main Document) (30) |
| Jun 9, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) (SEE ATTACHED PATENT REPORTS) (Attachments: # 1 Patent/Trademark Report, # 2 Patent/Trademark Report)(apk) (Entered: 06/12/2023) (Patent/Trademark Report) (1) |
| Jun 9, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) (SEE ATTACHED PATENT REPORTS) (Attachments: # 1 Patent/Trademark Report, # 2 Patent/Trademark Report)(apk) (Entered: 06/12/2023) (Patent/Trademark Report) (1) |
